(Z)-Endoxifen as a Potential Modulator of Utrophin Pathways in Duchenne Muscular Dystrophy: A Mechanistic and Transcriptomic Perspective.

Remmel HL, Hammer SS, Blackburn SM, Quay SC

Open source

DOI
10.2147/dnnd.s574524
Published
2026
Container
Degenerative neurological and neuromuscular disease
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.2147/dnnd.s574524,
  title = {(Z)-Endoxifen as a Potential Modulator of Utrophin Pathways in Duchenne Muscular Dystrophy: A Mechanistic and Transcriptomic Perspective.},
  author = {Remmel HL and Hammer SS and Blackburn SM and Quay SC},
  year = {2026},
  journal = {Degenerative neurological and neuromuscular disease},
  doi = {10.2147/dnnd.s574524},
  url = {https://doi.org/10.2147/dnnd.s574524}
}

RIS

TY  - JOUR
TI  - (Z)-Endoxifen as a Potential Modulator of Utrophin Pathways in Duchenne Muscular Dystrophy: A Mechanistic and Transcriptomic Perspective.
AU  - Remmel HL
AU  - Hammer SS
AU  - Blackburn SM
AU  - Quay SC
PY  - 2026
JO  - Degenerative neurological and neuromuscular disease
DO  - 10.2147/dnnd.s574524
UR  - https://doi.org/10.2147/dnnd.s574524
ER  - 

APA

HL, R., SS, H., SM, B., & SC, Q. (2026). (Z)-Endoxifen as a Potential Modulator of Utrophin Pathways in Duchenne Muscular Dystrophy: A Mechanistic and Transcriptomic Perspective.. Degenerative neurological and neuromuscular disease. https://doi.org/10.2147/dnnd.s574524

Source records